Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses
- PMID: 36584564
- DOI: 10.1016/j.ejrad.2022.110670
Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses
Abstract
Objective: Evaluation of the diagnostic performance and reproducibility of the Ovarian-Adnexal Reporting and Data System (O-RADS) Magnetic Resonance Imaging (MRI) risk stratification system based on enhanced non-dynamic contrast-enhanced (non-DCE) MRI in the diagnosis of adnexal masses.
Methods: Patients who underwent conventional pelvic enhanced non-DCE MRI examination within one month prior to surgery formed the study population. Two experienced radiologists independently evaluated the images and assigned a score according to the O-RADS MRI risk stratification system. One of the radiologists reviewed the images and reassigned the scores after three months. Intra- and inter-observer agreement was evaluated with the k coefficient value. The adnexal masses that attained scores between 1 and 3 were considered benign, while those with scores of 4 or 5 were considered malignant. Analyses were conducted to determine the sensitivity, specificity, positive and negative predictive values, and receiver operating characteristic (ROC) curve, which were then used for evaluating the diagnostic efficacy of the developed system based on enhanced non-DCE MRI scan. The reference standard was histology.
Results: A total of 308 patients (mean age: 42.09 ± 12.42 years, age range: 20-84 years) were enrolled in the study. Among the 362 adnexal masses from the included patients, there were 320 benign masses and 42 malignant masses. In the case of three readers, there were no malignant tumors scored 1-2. The O-RADS MRI score ≥ 4 was associated with malignancy resulted in a good diagnostic efficacy with the areas under the curve (AUC) values of 0.918 (95 % CI, 0.864-0.972), 0.905 (95 % CI, 0.842-0.968), and 0.882 (95 % CI, 0.815-0.950), the sensitivity values of 90.5 % (95 % CI, 87.5-93.5 %), 85.7 % (95 % CI, 82.1-89.3 %), and 83.3 % (95 % CI, 79.5-87.2 %), and the specificity values of 93.1 % (95 % CI, 90.5-95.7 %), 95.3 % (95 % CI, 93.1-97.5 %), and 93.1 % (95 % CI, 90.5-95.7 %) obtained for the three readers, respectively. Excellent intra-observer agreement and inter-observer agreement were observed with the k values of 0.883 (95 % CI, 0.814-0.952) and 0.848 (95 % CI, 0.770-0.926), respectively.
Conclusions: The O-RADS MRI risk stratification system based on enhanced non-DCE MRI scans exhibited high accuracy and reproducibility in the prediction of adnexal masses malignancy. Enhanced non-DCE MRI scan may offer an alternative diagnostic tool when DCE is not possible.
Keywords: Dynamic contrast-enhanced; Ovarian-adnexal reporting and data system; Receiver operating characteristic.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Diagnostic performance of the O-RADS MRI system for magnetic resonance imaging in discriminating benign and malignant adnexal lesions: a systematic review, meta-analysis, and meta-regression.Diagn Interv Radiol. 2025 Apr 28;31(3):171-179. doi: 10.4274/dir.2024.242784. Epub 2024 Jul 8. Diagn Interv Radiol. 2025. PMID: 38973658 Free PMC article.
-
Value of MRI-Based Ovarian-Adnexal Reporting and Data System for the Diagnosis of Adnexal Masses.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Dec;46(6):909-917. doi: 10.3881/j.issn.1000-503X.16176. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024. PMID: 39773510
-
Diagnostic Performance of O-RADS US (Version 2019 and Version 2022) Incorporating Acoustic Shadowing by Junior Radiologists: Analyzing 1061 Adnexal Masses.J Ultrasound Med. 2025 May;44(5):845-855. doi: 10.1002/jum.16644. Epub 2025 Jan 10. J Ultrasound Med. 2025. PMID: 39791550
-
Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.JAMA Netw Open. 2020 Jan 3;3(1):e1919896. doi: 10.1001/jamanetworkopen.2019.19896. JAMA Netw Open. 2020. PMID: 31977064 Free PMC article.
-
Diagnostic performance of contrast-enhanced ultrasound (CEUS) combined with Ovarian-Adnexal Reporting and Data System (O-RADS) ultrasound risk stratification for adnexal masses: a systematic review and meta-analysis.Clin Radiol. 2024 Sep;79(9):e1167-e1175. doi: 10.1016/j.crad.2024.05.021. Epub 2024 Jun 7. Clin Radiol. 2024. PMID: 38942707
Cited by
-
The value of a radiomics model in predicting ovarian malignancy: a retrospective multi-center comparison with O-RADS and radiologists.Insights Imaging. 2025 Jul 31;16(1):163. doi: 10.1186/s13244-025-02047-w. Insights Imaging. 2025. PMID: 40745233 Free PMC article.
-
Navigating Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging (O-RADS MRI): A Review of Its Evolution, Current Advances, and Persistent Challenges in Ovarian Imaging.Cureus. 2025 Jun 25;17(6):e86717. doi: 10.7759/cureus.86717. eCollection 2025 Jun. Cureus. 2025. PMID: 40718198 Free PMC article. Review.
-
O-RADS MRI scoring system: key points for correct application in inexperienced hands.Insights Imaging. 2024 Apr 12;15(1):107. doi: 10.1186/s13244-024-01670-3. Insights Imaging. 2024. PMID: 38609573 Free PMC article.
-
Diagnostic performance of a modified O-RADS classification system for adnexal lesions incorporating clinical features.Abdom Radiol (NY). 2025 Feb;50(2):953-965. doi: 10.1007/s00261-024-04538-8. Epub 2024 Aug 20. Abdom Radiol (NY). 2025. PMID: 39164457
-
Diagnostic performance of the O-RADS MRI system for magnetic resonance imaging in discriminating benign and malignant adnexal lesions: a systematic review, meta-analysis, and meta-regression.Diagn Interv Radiol. 2025 Apr 28;31(3):171-179. doi: 10.4274/dir.2024.242784. Epub 2024 Jul 8. Diagn Interv Radiol. 2025. PMID: 38973658 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
